1. Genital HPV Infection - CDC Fact Sheet ". Centers for Disease Control and Prevention (CDC). 2009-11-24. Retrieved 2011-05-26
2. ZhouJ, Sun XY, Stenzel DJ, Frazer IH. (1991). "Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles." Virology 1991;185: 251–57.
3. Gangulu,N; Parihar, SP (2009). "Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis". Journal of biosciences 34 (1): 113–23.
4. Chaturvedi,Anil; Maura L. Gillison. (2010). "Human Papillomavirus and Head and Neck Cancer" .Epidemiology, Pathogenesis, and Prevention of Head and Neck Cancer.2010, 87-116, DOI: 10.1007/978-1-4419-1472-9_5
5. Schiffman M, Castle PE (2003). "Human papillomavirus: epidemiology and public health". Arch Pathol Lab Med 127 (8): 930–4
6. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in China . Summary Report 2010.
7. Bruni L ； Diaz M ； Castellsague X. (2010). "Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings". J Infect Dis .2010V202N12:1789-99
8. “ Human Papillomavirus (HPV) and Genital Warts: Frequently Asked Questions ”. U.S.Department of Health and Human Services. 2009-01-01. Retrieved 2011-05-26
9. “ LEARN ABOUT HPV: Fast Facts ”. ASHA: HPV and Cervical Cancer Prevention Resource Center . Retrieved 2011-05-26
10. " Human Papillomavirus (HPV) and Genital Warts: Transmission ". National Institute of Allergy and Infectious Disease.2007-02-07. Retrieved 2011-05-26.
11. Lacey CJ ； Lowndes CM ； Shah KV. (2006). “Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease”. Vaccine, 2006V24 Suppl 3N:S3/35-41
12. Parkin DM (2006). "The global health burden of infection-associated cancers in the year 2002". Int. J. Cancer 118 (12): 3030–44
13. Silvia de Sanjose.(2010). " Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study". Lancet Oncol 2010; 11: 1048–56
14. “ HPV-Associated Cancers in the US ”. Centers for Disease Control and Prevention (CDC). 2008-11-18. Retrieved 2011-05-26
15. Parkin DM, Bray F, Ferlay J, Pisani P.(2005). "Global cancer statistics, 2002".CA Cancer J Clin 2005; 55: 74–108.
16. Walboomers JM,Jacobs MV,Manes MM,et al.(1999). “Human papillomavirus is a necessary cause of invasive cervical cancer worldwide”. J Pathol,1999,189:12-19
17.Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S.(2007)." Human papillomavirus and cervical cancer". The Lancet 2007; 370(9590):890–907.
18. “ STD Treatment Guidelines , 2010”. Centers for Disease Control and Prevention (CDC). 2010-11-16. Retrieved 2011-05-26
19. " Human Papillomaviruses and Cancer: Fact Sheet ". National Cancer Institute. 2010-12-13. Retrieved 2011-05-26.
20. " HPV Vaccine - Questions & Answers ". Centers for Disease Control and Prevention (CDC). 2011-04-06. Retrieved 2011-05-26
21. Canavan TP, Doshi NR (2000). "Cervical cancer.". Am Fam Physician 61 (5): 1369–76
22. Rajendra A Kerkar, Yogesh V Kulkarni.(2006)."Screening for cervical cancer:an overview".J Obstet Gynecol India 56(2):115-122
23. Qiao YL;Sellors JW; Eder PS,et al.(2008). "A new HPV- DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China ".Lancet Oncol. 2008V9N10:929-36
24. ACOG Practice Bulletin no. 109: Cervical cytology screening.;Obstet Gynecol.2009V114N6:1409-20
25. " HPV and Men - Fact Sheet". Centers for Disease Control and Prevention (CDC). 2010-10-14. Retrieved 2011-05-26
26.“ 卫生部、全国妇联关于印发《农村妇女“两癌”检查项目管理方案》的通知 ” . 中华人民共和国卫生部 . 2009-06-30 .
27.“ FDA: Gardasil approved to prevent anal cancer. ”. Food and Drug Administration(FDA). 2010-11-22. Retrieved 2011-05-26.
28. “ CDC recommendation for HPV vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) ” Centers for Disease Control and Prevention (CDC). 2007-03-12. Retrieved 2011-05-26
29. " ACOG Releases HPV Vaccine Recommendations for Ob-Gyns ". The American Congress of Obstetricians and Gynecologiests(ACOG).2008-08-08. Retrieved 2011-05-26 .
30."Status of Recently Submitted, Licensed, and Recommended Vaccines ". American Academy of Pediatrics.2011-05-26. Retrieved 2011-05-26.
31. Shao-ming Wang, You-lin Qiao. (2010). "HPV 预防性疫苗在中国的应用前景 ". Oncology Progress. March 2010; 8(2):134-138
32. " June 8, 2006 Approval Letter - Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant ". Food and Drug Administration(FDA). 2006-08-08. Retrieved 2011-05-26.
33. “ Information from CDC and FDA on the Safety of Gardasil® Vaccine ”. Centers for Disease Control and Prevention (CDC). 2008-07-22. Retrieved 2011-05-26
34. " The Nobel Prize in Physiology or Medicine 2008 ". Nobelprize.org. 2008-10-06. Retrieved 2011-05-26
35. " FDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal Cancers ". Food and Drug Administration(FDA). 2008-09-12. Retrieved 2011-05-26.
36. " October 16, 2009 Approval Letter - Cervarix ". Food and Drug Administration(FDA). 2009-10-16. Retrieved 2011-05-26.
37. " FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys " . Food and Drug Administration(FDA). 2009-10-16. Retrieved 2011-05-26.
Bibliographic References (haven’t been cited)
Marlow LAV. (August, 2011). HPV vaccination among ethnic minotities in the UK : knowledge, acceptability and attitudes. British Journal of Cancer 105, 486-492
38. Baggs, J., J. Gee, et al. (2011). "The Vaccine Safety Datalink: a model for monitoring immunization safety." Pediatrics 127 Suppl 1: S45-53.
39. Bendik, M. K., R. M. Mayo, et al. (2011). "Knowledge, Perceptions, and Motivations Related to HPV Vaccination Among College Women." J Cancer Educ
40. Freed, G. L., S. J. Clark, et al. (2011). "Sources and perceived credibility of vaccine-safety information for parents." Pediatrics 127 Suppl 1: S107-112
41. Haber, P., J. Iskander, et al. (2011). "Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety." Pediatrics 127 Suppl 1: S39-44.
42. Healy, C. M. and L. K. Pickering (2011). "How to communicate with vaccine-hesitant parents." Pediatrics 127 Suppl 1: S127-133.
43. Juraskova, I. , R. A. Bari, et al. (2011). "HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior?" Womens Health Issues 21(1): 71-79.
44. Kennedy, A., M. Basket, et al. (2011). "Vaccine attitudes, concerns, and information sources reported by parents of young children: results from the 2009 HealthStyles survey." Pediatrics 127 Suppl 1: S92-99.
45.LaRussa, P. S., K. M. Edwards, et al. (2011). "Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network." Pediatrics 127 Suppl 1: S65-73.
46. Pineda, D. and M. G. Myers (2011). "Finding reliable information about vaccines." Pediatrics 127 Suppl 1: S134-137.
47. Schuler, C. L., P. L. Reiter, et al. (2011). "Human papillomavirus vaccine and behavioural disinhibition." Sex Transm Infect
48. Salmon, D. A., A. Akhtar, et al. (2011). "Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program." Pediatrics 127 Suppl 1: S78-86
49. Walther, S. (2011). "A parent's decision on immunization: making the right choice." Pediatrics 127 Suppl 1: S5-8.
50. Yih, W. K., M. Kulldorff, et al. (2011). "Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project." Pediatrics 127 Suppl 1: S54-64.
51. Yingshan Shi, et al. (pending) Factors affecting vaccination acceptance for children against the seasonal and H1N1 influenzas during a pandemic.
52. Askelson, N. M., S. Campo, et al. (2010). "Factors related to physicians' willingness to vaccinate girls against HPV: the importance of subjective norms and perceived behavioral control." Women Health 50(2): 144-158.
53. Barnack, J. L., D. M. Reddy, et al. (2010). "Predictors of parents' willingness to vaccinate for human papillomavirus and physicians' intentions to recommend the vaccine." Womens Health Issues 20(1): 28-34.
54.Ferris, D. G., L. Cromwell, et al. (2010). "Most parents do not think receiving human papillomavirus vaccine would encourage sexual activity in their children." J Low Genit Tract Dis 14(3): 179-184.
55. Harper, D. M. and K. B. Williams (2010). "Prophylactic HPV vaccines: current knowledge of impact on gynecologic premalignancies." Discov Med 10(50): 7-17.
55.Young, A. (2010). "HPV vaccine acceptance among women in the Asian Pacific: a systematic review of the literature." Asian Pac J Cancer Prev 11(3): 641-649.
56. Gerend, M. A., E. Weibley , et al. (2009). "Parental response to human papillomavirus vaccine availability: uptake and intentions." J Adolesc Health45(5): 528-531.
57.Goldstein MA, Goodman A, del Carmen MG, Wilbur DC (March 2009). "Case records of the Massachusetts General Hospital . Case 10-2009. A 23-year-old woman with an abnormal Papanicolaou smear". N. Engl. J. Med. 360 (13): 1337–44.
58.Li J, Li LK, Ma JF, Wei LH, Niyazi M, Li CQ, et al.(2009). " Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China ". Vaccine. 2009;27(8):1210–15
59.Luciani, S., B. Jauregui, et al. (2009). "Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries." Immunotherapy 1(5): 795-807.
60.Stinchfield, P. K. (2008). "Practice-proven interventions to increase vaccination rates and broaden the immunization season." Am J Med 121(7 Suppl 2): S11-21.
61.Song D. (2007). "The prevalence HPV infections and awareness of HPV vaccine among women in Shanxi Province ". In: China doctor/ master dissertations fulltext database of the China National Knowledge Infrastructure (CNKI) 2007.Available at: http://www.global.cnki.net/grid20/index.htm
62.Duval, B., V. Gilca, et al. (2007). "Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs." Vaccine25(45): 7841-7847.
63.Lee, P. W., T. T. Kwan, et al. (2007). "Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong ." Prev Med 45(2-3): 130-13
64.Lowy DR, Schiller JT (2006). "Prophylactic human papillomavirus vaccines". J. Clin. Invest. 116 (5): 1167–73
65.Lin, C. J., M. P. Nowalk, et al. (2006). "Beliefs and attitudes about influenza immunization among parents of children with chronic medical conditions over a two-year period." J Urban Health 83(5): 874-883.
66.Smith, P. J., A. M. Kennedy, et al. (2006). "Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage." Pediatrics 118(5): e1287-1292.
67. Kahn, J. A., G. D. Zimet, et al. (2005). "Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes." J Adolesc Health 37(6): 502-510.
68. Nowalk, M. P., R. K. Zimmerman, et al. (2005). "Parental perspectives on influenza immunization of children aged 6 to 23 months." Am J Prev Med 29(3): 210-214.
69. Qianqian Qin, et al. (2003). " Epidemiological Analysis of STD in China , 2003". Disease Surveillance. 2004,19,(10)
70. Centers for Disease Control and Prevention.(1999). "Vaccine-preventable diseases: improving vaccination coverage in children, adolescents, and adults". Morb Mortal Wkly Rep.1999; 48:RR8-14 |